Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06398509 · ClinicalTrials.gov registry record · NA

A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children

A NA study of Obesity, Childhood, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
576
Enrollment target
2
Study locations

NCT06398509: Recruiting NA study of Obesity, Childhood, sponsored by University of California, San Francisco.

NCT06398509 is a NA study of Obesity, Childhood that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 576 participants, above the 333-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (73% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06398509, a NA study of Obesity, Childhood, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
576 participants
Enrollment target
2
Study locations

Study Summary

The goal of this study is to evaluate the impact of a primary care based intervention to promote optimal feeding, screen time and sleep practices among low-income Latino infants and toddlers. Infants and caregivers will receive brief health education and coaching sessions from health educators at primary care visits in the first two years of life as well as two text messages per week with health information and tips. Half of the participants will receive the Futuros Fuertes 2.0 intervention that includes health coaching and education on infant feeding, screen time and sleep (intervention group). The other half will receive health coaching and education on safety, home management of childhood illnesses, and promotion of language development (control group). We will look at the impact of the Futuros Fuertes 2.0 intervention on child BMI and various health behaviors.

Primary Outcome

BMI Z-score based on WHO growth curves

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Futuros Fuertes 2.0

Study Locations (2)

California

  • Children's Health Center San Francisco General Hospital - San Francisco
  • Valley Health Center Sunnyvale - Sunnyvale

Trial Details

FieldValue
Enrollment Target 576 participants
Start Date 2024-05-13
Est. Completion 2028-12
Phase NA

What NCT06398509 shows while recruiting

NCT06398509 is an interventional study that assigns participants to a tested intervention. The registered 576 participants enrollment target is mid-sized for trials with a published cap, above the 333-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (73% higher).

The record links to 1 condition, with Obesity, Childhood appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT06398509 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06398509 about?

NCT06398509 is a clinical study titled "A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children". The goal of this study is to evaluate the impact of a primary care based intervention to promote optimal feeding, screen time and sleep practices among low-income Latino infants and toddlers. Infants and caregivers will receive brief health education and coaching sessions from health educators at pr...

What is the current status of trial NCT06398509?

This trial is currently recruiting. It is a NA study. The enrollment target is 576 participants. The study started on 2024-05-13. Estimated completion is 2028-12.

What conditions does trial NCT06398509 study?

This clinical trial studies the following conditions: Obesity, Childhood.

What interventions are being tested in trial NCT06398509?

The interventions under investigation include: Control (BEHAVIORAL), Futuros Fuertes 2.0 (BEHAVIORAL).

Who is sponsoring clinical trial NCT06398509?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06398509 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity, Childhood

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06398509's enrollment target sits among peer trials

576 10th of 53 higher than 44 of 53 other Obesity, Childhood trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity, Childhood trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04931810 · 576 participants · NA

    Urban and Reservation Implementation of All Nations Breath of Life

  • NCT05179369 · 576 participants · NA

    Well-Mama Community Doula Navigator Study

  • NCT02610439 · 575 participants

    Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

  • NCT05919264 · 575 participants · Phase 1

    FOG-001 in Locally Advanced or Metastatic Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06398509, the US trial registry maintained by the National Library of Medicine. NCT06398509 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.